Labcyte Announces Partnership with AstraZeneca

News   Nov 21, 2015

 
Labcyte Announces Partnership with AstraZeneca
 
 
 

RELATED ARTICLES

New Drug to Treat Herpes Simplex Virus Infection?

News

Researchers have now identified a small drug molecule that can clear the HSV-1 infection in the cells of the cornea -- the clear outer layer of the eyeball -- and works completely differently than the currently-available drugs, making it a promising potential option for patients who have developed resistance.

READ MORE

Lonza to Establish Cell- and Gene-Therapy Centers of Excellence to Accelerate Growth

News

Lonza will establish Centers of Excellence for Cell and Gene Therapy to support and accelerate the growth of this priority area for the company.

READ MORE

Gaining a Deeper Understanding of Protein Kinases Involved in Cancer

News

Vaccinia-related protein kinases VRK1 and VRK2, which are involved in cell proliferation, are considered potential targets for treatment of prostate, ovarian, colorectal and other kinds of cancer. To obtain a deeper understanding of the role of these enzymes in human cells, in the contexts of both wellness and disease, researchers are working on the development of small synthetic molecules capable of modulating their activity in study models.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE